Multiple Myeloma| BCMA-Directed Therapy in Multiple Myeloma: Expert Opinions and Patient Perspectives — Part 1

Featuring perspectives from Dr Elizabeth O'Donnell, including the following topics:

• Introduction: Quality of Life in Multiple Myeloma (0:00)
• CAR (Chimeric Antigen Receptor) T-Cell Therapy (9:29)
• Bispecific Antibodies (33:08)
• Belantamab Mafodotin (43:11)

CME information and select publications